Medicare Enrolled
Dr. Marc Maskowitz, M.D.
Addiction Medicine (Anesthesiology) Physician · Sacramento, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Speaking/Promotional
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Maskowitz from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Maskowitz?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Maskowitz
Dr. Marc Maskowitz is an addiction medicine physician in Sacramento, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Maskowitz performed 12,902 Medicare services across 566 unique beneficiaries.
Between the years covered by Open Payments, Dr. Maskowitz received a total of $29,845 from 51 pharmaceutical and/or device companies across 440 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in addiction medicine (anesthesiology) physician. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Maskowitz is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 33% volume in CA
$29,845 industry payments
Medicare Practice Summary
Medicare Utilization ↗12,902
Medicare services
Top 33% in CA for addiction medicine (anesthesiology) physician
566
Unique beneficiaries
$17
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~679 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Botox injection, per unit An injection of onabotulinumtoxinA, a medication used to temporarily relax muscles or reduce gland activity. The dose is measured in units, with this code representing a single unit administered. |
11,800 | $5 | $10 |
| Telephone medical discussion, 11-20 minutes A phone conversation with a physician lasting between 11 and 20 minutes. |
458 | $73 | $262 |
| Injection of anesthetic or steroid into sacroiliac joint with imaging guidance This procedure involves injecting an anesthetic or steroid medication into the joint connecting the lower spine and hip bone. Imaging guidance is used to ensure accurate placement of the injection. |
89 | $174 | $1,506 |
| Sacral spine nerve root injection with imaging guidance An injection of anesthetic and/or steroid medication into a sacral spine nerve root. The procedure uses imaging guidance to ensure accurate placement. |
61 | $235 | $1,582 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the lower or sacral spine while using imaging guidance to ensure accurate placement. |
59 | $206 | $620 |
| Bilateral facial and neck nerve muscle paralysis injection Injection of a chemical agent to paralyze muscles in the face and neck on both sides. |
59 | $122 | $220 |
| Facet joint injection, second level, with imaging guidance An injection into a lower or sacral spine facet joint using imaging guidance for the second level treated. |
56 | $110 | $475 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
42 | $50 | $400 |
| Ultrasound-guided large joint aspiration or injection This procedure uses ultrasound imaging to guide the removal of fluid from or the injection of medication into a large joint. |
41 | $99 | $300 |
| Facet joint nerve destruction, single joint A procedure to destroy nerves in a single lower or sacral spinal facet joint using imaging guidance to target pain signals. |
37 | $546 | $1,000 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional lower or sacral spinal facet joint. |
35 | $302 | $600 |
| Spine facet joint injection with imaging guidance, single level An injection is administered into a single facet joint of the upper or middle spine while using imaging guidance to ensure accurate placement. |
34 | $172 | $650 |
| Facet joint injection, second level, with imaging An injection into a second spinal facet joint in the upper or middle spine, guided by imaging to ensure accurate placement. |
34 | $88 | $475 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
24 | $93 | $1,200 |
| Spinal injection with imaging guidance A procedure where medication is injected into the middle or upper part of the spinal canal. Imaging technology is used to guide the needle to the correct location. |
22 | $222 | $3,591 |
| Injection into lower spine canal with imaging guidance A procedure where a substance is injected into the lower part of the spinal canal. The injection is performed using imaging guidance to ensure accurate placement. |
17 | $224 | $1,912 |
| Facet joint nerve destruction, single joint This procedure uses imaging guidance to destroy the nerves supplying a single upper or middle spinal facet joint. It is performed to interrupt pain signals from that specific joint. |
17 | $367 | $1,000 |
| Facet joint nerve destruction, additional joint This procedure uses imaging guidance to destroy nerves in an additional upper or middle spinal facet joint. |
17 | $244 | $600 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$29,845
Total received (2018-2024)
Avg $4,264/year across 7 years
Top 25% in CA for addiction medicine (anesthesiology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
51
Companies
440
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$16,347 (54.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,497 (45.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$634
2023
$690
2022
$873
2021
$1,272
2020
$2,230
2019
$6,804
2018
$17,342
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Abbott Laboratories
$246
Medtronic, Inc.
$209
SPR Therapeutics, Inc
$66
Boston Scientific Corporation
$57
Collegium Pharmaceutical, Inc.
$42
Radius Health, Inc.
$15
Top 3 companies account for 82.1% of 2024 payments
All-time payments by company (2018-2024) ›
Indivior Inc.
$9,299
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$7,165
Medtronic USA, Inc.
$2,379
Abbott Laboratories
$1,976
Titan Pharmaceuticals, Inc.
$1,347
Medtronic, Inc.
$910
Nuvectra Corporation
$885
SI-BONE, Inc.
$745
Stimwave Technologies Incorporated
$620
Nevro Corp.
$594
Merz North America, Inc.
$490
Almatica Pharma LLC
$414
Collegium Pharmaceutical, Inc.
$404
ARBOR PHARMACEUTICALS, INC.
$267
BOSTON SCIENTIFIC CORPORATION
$209
PFIZER INC.
$188
US WorldMeds, LLC
$187
ASSERTIO THERAPEUTICS, Inc.
$161
Siemens Medical Solutions USA, Inc.
$143
Amgen Inc.
$138
Pacira Pharmaceuticals Incorporated
$116
MERZ NORTH AMERICA, INC.
$100
Relievant Medsystems, Inc.
$96
BioDelivery Sciences International, Inc.
$88
Radius Health, Inc.
$84
Orexo US, Inc.
$68
SPR Therapeutics, Inc
$66
Boston Scientific Corporation
$57
ABBVIE INC.
$54
Purdue Pharma L.P.
$46
Assertio Therapeutics, Inc.
$43
Stryker Corporation
$41
GRT US Holding, Inc.
$40
Lundbeck LLC
$39
Electronic Waveform Lab, Inc.
$38
Scilex Pharmaceuticals Inc.
$31
Shionogi Inc
$28
Forte Bio-Pharma LLC
$26
Merz Pharmaceuticals, LLC
$25
Biohaven Pharmaceutical Holding Company Ltd.
$25
SI-BONE, INC.
$24
Novo Nordisk Inc
$24
RedHill Biopharma Inc.
$23
Takeda Pharmaceuticals U.S.A., Inc.
$21
Sentynl Therapeutics, Inc.
$20
Daiichi Sankyo Inc.
$18
Allergan, Inc.
$18
Lilly USA, LLC
$17
INSYS Therapeutics Inc
$16
Arbor Pharmaceuticals, Inc.
$15
BIODELIVERY SCIENCES INTERNATIONAL, INC.
$14
Top 3 companies account for 63.1% of all-time payments
Associated products mentioned in payments ›
ADAPTIVESTIM · Algovita · Amitiza · BELBUCA · BOTOX · BUNAVAIL 2.1 mg 30-count box · Belbuca · CFNS StimQ Peripheral Nerve StimulatorSystem · Cambia · EMGALITY · ETERNA · EVENITY · FLECTOR · GENERAL THERAPIES · GENERAL PAIN MANAGEMENT · GRALISE · Gralise · Horizant · INTELLIS · INTELLIS ADAPTIVESTIM · IVS - MULTIGEN 2RF · Infinion 16 · Intracept · Iovera · LIORESAL · LUCEMYRA · LYRICA · Levorphanol · Lucemyra/Lofexidine · Morphabond ER · Movantik · N'VISION · NALOCET · NAPRELAN · NURTEC ODT · Nucynta · Ozempic · PROCLAIM · Probuphine · Proclaim Family of SCS IPGs · Proclaim IPG · Qutenza · RELISTOR · RELISTOR ORAL · RESTORE · SPRINT PNS System · SUBLOCADE · SUBOXONE SUBLINGUAL FILM · SUBSYS · SYMPROIC · Senza Spinal Cord Stimulation System · Symproic · Syva Rapids Instrument · Syva Rapids Reagents/Test Kit/Clinical Utilization · Tymlos · VYEPTI · WAVEWRITER ALPHA · XEOMIN · XIFAXAN · XTAMPZA · Xeomin · ZTLido 30 POUCH in 1 CARTON 1 PATCH in 1 POUCH · Zipsor · Zubsolv · iFuse Implant
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
The majority of payments (55%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in addiction medicine (anesthesiology) physician and does not inherently indicate bias, but patients may wish to be aware.
Geographic Context
Addiction medicine physicians within 10 mi
1
Per 100K population
0.1
County median income
$88,724
Nearest hospital
KAISER FOUNDATION HOSPITAL - SACRAMENTO
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Maskowitz is a mixed practice specialist, with moderate Medicare volume, with speaking/promotional industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Maskowitz experienced with botox injection, per unit?
Based on Medicare claims data, Dr. Maskowitz performed 11,800 botox injection, per unit services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Maskowitz receive payments from pharmaceutical companies?
Yes. Dr. Maskowitz received a total of $29,845 from 51 companies across 440 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Maskowitz's costs compare to other addiction medicine physicians in Sacramento?
Dr. Maskowitz's average Medicare payment per service is $17. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Maskowitz) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Addiction Medicine Physicians in Sacramento
Browse addiction medicine physicians in Sacramento ranked by procedure volume and transparency data.
Highest volume
Top Addiction Medicine Physicians in CA
Addiction medicine physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Addiction Medicine Physicians in CA
Which CA addiction medicine physicians receive the most from drug and device companies.
By company
Indivior Inc. Payments to Doctors
See all physicians who received payments from Indivior Inc.
By company
Salix Pharmaceuticals, a division of Bausch Health US, LLC Payments to Doctors
See all physicians who received payments from Salix Pharmaceuticals, a division of Bausch Health US, LLC.
By company
Medtronic USA, Inc. Payments to Doctors
See all physicians who received payments from Medtronic USA, Inc.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology